Mouse Anti-ERAS Recombinant Antibody (CBFYE-1089) (V2LY-0825-LY587)

Pudewell, S., Lissy, J., Nakhaeizadeh, H., Taha, M. S., Akbarzadeh, M., Rezaei Adariani, S., ... & Ahmadian, M. R. (2022). Physical interaction between embryonic stem cell-expressed Ras (ERas) and Arginase-1 in quiescent hepatic stellate cells. Cells, 11(3), 508.

Suarez-Cabrera, C., Ojeda-Perez, I., Sanchez-Baltasar, R., Page, A., Bravo, A., Navarro, M., & Ramirez, A. (2021). ERAS, a Member of the Ras Superfamily, Acts as an Oncoprotein in the Mammary Gland. Cancers, 13(21), 5588.

Tian, H., Wang, W., Meng, X., Wang, M., Tan, J., Jia, W., ... & Zhou, Q. (2020). ERas enhances resistance to cisplatin-induced apoptosis by suppressing autophagy in gastric cancer cell. Frontiers in cell and developmental biology, 7, 375.

Liu, Y., Qin, P., Wu, R., Du, L., & Li, F. (2020). ERas regulates cell proliferation and epithelial–mesenchymal transition by affecting Erk/Akt signaling pathway in pancreatic cancer. Human cell, 33(4), 1186-1196.

Pan, J., & Zhao, L. X. (2020). Epithelial-mesenchymal transition suppresses ERas to activate autophagy in retinal pigment epithelial cells in proliferative vitreoretinopathy. Eur Rev Med Pharmacol Sci, 24(9), 4627-4634.

Ikink, G. J., Boer, M., Bakker, E. R., Vendel-Zwaagstra, A., Klijn, C., Ten Hoeve, J., ... & Hilkens, J. (2018). Insertional mutagenesis in a HER2-positive breast cancer model reveals ERAS as a driver of cancer and therapy resistance. Oncogene, 37(12), 1594-1609.

Suárez-Cabrera, C., de la Peña, B., González, L. L., Page, A., Martínez-Fernández, M., Casanova, M. L., ... & Navarro, M. (2018). The Ras-related gene ERAS is involved in human and murine breast cancer. Scientific reports, 8(1), 1-17.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols